 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Foundations of Sequence Variant Interpretation

Introduction to Clinical Variant Interpretation

Variant Nomenclature and Essential Terminology

Sources of Evidence for Variant Interpretation

ACMG/AMP and ClinGen Classification Frameworks

Overview of the ACMG/AMP Five-Tier Classification System

ACMG/AMP Evidence Codes and Strength Levels

Combining Evidence to Reach a Classification

ClinGen Specifications and Expert Panel Guidance

Evaluating Key Lines of Evidence

Population Frequency Evidence

Computational, Conservation, and Predicted Splicing Evidence

Case-Level, Segregation, and Phenotype Evidence

Loss-of-Function and Variant-Type Considerations

Functional Assays and Evidence Evaluation

Role of Functional Assays in Variant Classification

Assessing Functional Assay Validity and Strength

Interpreting RNA and Splicing Assays

Variant Classification Workflow and Reporting

A Stepwise Variant Interpretation Workflow

Communicating Classifications in Clinical Reports

Applied Classification Case Study

Reclassification and Continuous Evidence Review

Why Variant Reclassification Occurs

Reclassification Workflows and Documentation

Data Sharing and Responsible Interpretation

Quiz

Question 1: Which ACMG/AMP classification indicates that available evidence is currently insufficient or conflicting?

Question 2: Which type of evidence can a well-validated functional assay provide when it demonstrates a damaging effect consistent with the disease mechanism?

Question 3: Why should a Variant of Uncertain Significance generally not be used as the sole basis for clinical management?

Question 4: What is the primary reason to consult ClinGen Variant Curation Expert Panel specifications when they are available?

Question 5: Which event is an appropriate trigger for reassessing a previously classified variant?

Survey and Feedback

Course Feedback Survey

Welcome to 'Applying ACMG and ClinGen Guidelines for Sequence Variant Classification,' a comprehensive online course designed for clinical geneticists, genetic counselors, laboratory directors, and genomic medicine professionals. In the rapidly evolving field of clinical genomics, accurate sequence variant interpretation is critical for patient diagnosis, management, and family counseling.

Welcome to 'Applying ACMG and ClinGen Guidelines for Sequence Variant Classification,' a comprehensive online course designed for clinical geneticists, genetic counselors, laboratory directors, and genomic medicine professionals. In the rapidly evolving field of clinical genomics, accurate sequence variant interpretation is critical for patient diagnosis, management, and family counseling. This course provides an in-depth exploration of the foundational principles and practical applications of the ACMG/AMP five-tier classification system and ClinGen Variant Curation Expert Panel specifications.

Throughout this program, you will learn how to systematically evaluate key lines of evidence, including population frequency, computational predictions, case-level segregation, and functional assays. We will guide you through the intricacies of combining evidence codes to reach robust, reproducible classifications—Pathogenic, Likely Pathogenic, Variant of Uncertain Significance (VUS), Likely Benign, and Benign. Furthermore, you will gain hands-on insights into interpreting RNA and splicing assays, navigating complex loss-of-function scenarios, and effectively communicating findings in clinical reports.

By the end of this course, you will have mastered a stepwise variant interpretation workflow, understand the critical triggers for variant reclassification, and recognize the importance of responsible data sharing in resources like ClinVar. Whether you are looking to refine your curation skills or establish standardized workflows in your laboratory, this course equips you with the evidence-based tools necessary to excel in genomic variant classification.

Applying ACMG and ClinGen Guidelines for Sequence Variant Classification

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>The accurate interpretation of sequence variants is a cornerstone of modern clinical genetics and genomic medicine, requiring a rigorous, evidence-based approach to ensure patient safety and effective clinical decision-making. This course provides a comprehensive examination of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) five-tier classification system, alongside the specialized guidance provided by the Clinical Genome Resource (ClinGen). By establishing a strong foundation in variant nomenclature, essential terminology, and the diverse sources of genomic evidence, learners will be equipped to navigate the complexities of variant interpretation. The curriculum systematically addresses the critical distinction between variant detection and clinical reporting, emphasizing the necessity of gene- and disease-specific evaluations in clinical practice.</p>

<p>Throughout this program, participants will engage with the systematic evaluation of key lines of evidence, including population frequencies, computational predictions, case-level segregation, and functional assays. The coursework details the structured workflow required to synthesize these disparate data points into a cohesive classification, ranging from Pathogenic to Benign, while addressing the nuanced handling of Variants of Uncertain Significance (VUS). Furthermore, the curriculum explores the critical processes of clinical reporting, continuous evidence review, and variant reclassification. By applying these standardized frameworks to practical case studies, professionals will develop the analytical skills necessary to responsibly interpret genomic data, communicate findings effectively in clinical reports, and contribute to the broader scientific community through responsible data sharing.</p>
        </div>
    </div>
</div>
